Computer-aided detection (CAD) developer Medicsight is planning a clinical studies program in China for its LungCAD and ColonCAD products.
A Chinese investigator team will lead the program, which will provide research to help improve Medicsight's CAD algorithms, according to the London-based firm. The Chinese team will collaborate with Medicsight's in-house clinical team in London, as well as two U.K. radiologists, Medicsight said.
In other Medicsight news, the firm has raised $7.5 million from a sale of 1.9 million shares of its common stock. The proceeds will be used to fund the firm's CAD software product initiatives, ongoing operations, and the acquisition of property and equipment.
By AuntMinnie.com staff writers
November 1, 2005
Related Reading
Medicsight, Viatronix partner, October 12, 2005
TeraRecon, Medicsight ally, August 19, 2005
Medicsight notches distribution trifecta, November 24, 2004
Copyright © 2005 AuntMinnie.com
